Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Revenue (2024 - 2025)

Prime Medicine filings provide 2 years of Revenue readings, the most recent being $838000.0 for Q4 2025.

  • On a quarterly basis, Revenue fell 61.61% to $838000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $4.6 million, a 55.28% increase, with the full-year FY2025 number at $4.6 million, up 55.28% from a year prior.
  • Revenue hit $838000.0 in Q4 2025 for Prime Medicine, down from $1.2 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $2.2 million in Q4 2024 to a low of $209000.0 in Q3 2024.